Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02428998
What this trial is testing

Safety for 24 Weeks Intake of Korean Red Ginseng in Adults

Who this might be right for
HealthyDiabetesHypertension+1 more
Korea Ginseng Corporation 1,000
Large-scale testing (Phase 3)Study completedNCT05814406
What this trial is testing

To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
JW Pharmaceutical 196
Not applicableStudy completedNCT05588258
What this trial is testing

Cost-effectiveness Evaluation of Two 10% Urea Creams in Patients With Diabetic Foot Syndrome

Who this might be right for
Diabetic Foot
Universidad Complutense de Madrid 20
Testing effectiveness (Phase 2)UnknownNCT01836172
What this trial is testing

YJP-14 Capsules for the Treatment of Endothelial Dysfunction in Patients With Diabetes Mellitus

Who this might be right for
Diabetic Complication
Han Wha Pharma Co., Ltd. 136
Early research (Phase 1)Study completedNCT03888053
What this trial is testing

BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers

Who this might be right for
Diabetic Foot Ulcer
Blue Blood Biotech Corp. 14
Large-scale testing (Phase 3)Study completedNCT00528372
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,067
Not applicableStudy completedNCT06099067
What this trial is testing

Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 239,990
Large-scale testing (Phase 3)Study completedNCT03875729
What this trial is testing

Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

Who this might be right for
Type 1 Diabetes Mellitus
Provention Bio, Inc. 328
Testing effectiveness (Phase 2)Ended earlyNCT04839575
What this trial is testing

Study of Latiglutenase in T1D/CD Patients

Who this might be right for
Celiac Disease
Entero Therapeutics 13
Testing effectiveness (Phase 2)Study completedNCT01847092
What this trial is testing

A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Ardelyx 154
Early research (Phase 1)Study completedNCT01275131
What this trial is testing

Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)

Who this might be right for
Type 1 Diabetes Mellitus
Halozyme Therapeutics 45
Testing effectiveness (Phase 2)Study completedNCT02057172
What this trial is testing

Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hanmi Pharmaceutical Company Limited 254
Testing effectiveness (Phase 2)Study completedNCT00111631
What this trial is testing

DPP-IV Inhibitor in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 218
Early research (Phase 1)Study completedNCT01620437
What this trial is testing

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 30
Testing effectiveness (Phase 2)Ended earlyNCT01206101
What this trial is testing

Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 3
Large-scale testing (Phase 3)Study completedNCT00231530
What this trial is testing

The Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet

Who this might be right for
ObesityDiabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 541
Testing effectiveness (Phase 2)Study completedNCT00423501
What this trial is testing

A GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 306
Early research (Phase 1)Study completedNCT00606112
What this trial is testing

A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers

Who this might be right for
Diabetes MellitusObesity
Genaera Corporation 28
Large-scale testing (Phase 3)Study completedNCT00951119
What this trial is testing

Device-guided Breathing Exercises on Blood Pressure in Diabetic Patients

Who this might be right for
Hypertension in Type 2 Diabetes
Medical Research Foundation, The Netherlands 48
Early research (Phase 1)Study completedNCT03165227
What this trial is testing

This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

Who this might be right for
Diabetic Nephropathies
Boehringer Ingelheim 75
Next Page